{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:31:30Z","timestamp":1787830290783,"version":"build-2784847793"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM121796"],"award-info":[{"award-number":["R01GM121796"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R35GM141478"],"award-info":[{"award-number":["1R35GM141478"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL126795"],"award-info":[{"award-number":["R01HL126795"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL131597"],"award-info":[{"award-number":["R01HL131597"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glucocorticoid (GC) therapy had been strongly recommended for pediatric sepsis (grade 1A). However, the recommendation was changed to grade 2C in 2020 due to weak evidence. About 32.8% of patients with pediatric septic develop relative adrenal insufficiency (RAI). But whether GC therapy should be determined by RAI status is controversial. This study utilized 21-day-old SF1CreSRBIfl\/fl mice as the first pediatric RAI mouse model to assess the pathogenesis of RAI and evaluate GC therapy. RAI mice exhibited a substantially higher mortality rate in cecal ligation and puncture and cecal slurry\u2013induced sepsis. These mice featured persistent inflammatory responses and were effectively rescued by GC therapy. RNA sequencing analysis revealed persistent inflammatory responses in RAI mice, caused by transcriptional dysregulation of AP-1 and NF-\u03baB, and cytokine-induced secondary inflammatory response. Our findings support a precision medicine approach to guide GC therapy for pediatric patients based on the status of RAI.<\/jats:p>","DOI":"10.1093\/infdis\/jiad369","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:46:12Z","timestamp":1693097172000},"page":"1166-1177","source":"Crossref","is-referenced-by-count":6,"title":["Relative Adrenal Insufficiency Is a Risk Factor for Pediatric Sepsis: A Proof-of-Concept Study"],"prefix":"10.1093","volume":"229","author":[{"given":"Dan","family":"Hao","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Nutritional Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Saha Cardiovascular Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Nutritional Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Cancer Biostatistics, College of Medicine, University of Kentucky , Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Mineo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center , Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W","family":"Shaul","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Texas Southwestern Medical Center , Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-An","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Nutritional Sciences"},{"name":"Saha Cardiovascular Research Center"},{"name":"Lexington VA Healthcare System"},{"name":"Department of Physiology, College of Medicine, University of Kentucky , Lexington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,27]]},"reference":[{"key":"2024041213283432200_jiad369-B1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"2024041213283432200_jiad369-B2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/PCC.0000000000002444","article-title":"Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"de Castro","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2024041213283432200_jiad369-B3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"2024041213283432200_jiad369-B4","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2024041213283432200_jiad369-B5","author":"Lovallo"},{"key":"2024041213283432200_jiad369-B6","volume-title":"Addison disease","author":"Munir","year":"2023"},{"key":"2024041213283432200_jiad369-B7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1523\/JNEUROSCI.2568-17.2018","article-title":"Corticosterone production during repeated social defeat causes monocyte mobilization from the bone marrow, glucocorticoid resistance, and neurovascular adhesion molecule expression","volume":"38","author":"Niraula","year":"2018","journal-title":"J Neurosci"},{"key":"2024041213283432200_jiad369-B8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41574-019-0185-7","article-title":"Adrenal function and dysfunction in critically ill patients","volume":"15","author":"T\u00e9blick","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2024041213283432200_jiad369-B9","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"2024041213283432200_jiad369-B10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1164\/rccm.200509-1369OC","article-title":"Diagnosis of adrenal insufficiency in severe sepsis and septic shock","volume":"174","author":"Annane","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2024041213283432200_jiad369-B11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Crit Care Med"},{"key":"2024041213283432200_jiad369-B12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.200911-1738OC","article-title":"A prospective multicenter study of adrenal function in critically ill children","volume":"182","author":"Menon","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2024041213283432200_jiad369-B13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"2024041213283432200_jiad369-B14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.110.3.563","article-title":"Assessment of adrenal function in the initial phase of meningococcal disease","volume":"110","author":"Bone","year":"2002","journal-title":"Pediatrics"},{"key":"2024041213283432200_jiad369-B15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00134-007-0699-7","article-title":"Adrenal response in children with septic shock","volume":"33","author":"Casartelli","year":"2007","journal-title":"Intensive Care Med"},{"key":"2024041213283432200_jiad369-B16","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00130478-200204000-00004","article-title":"Adrenal function in pediatric critical illness","volume":"3","author":"Menon","year":"2002","journal-title":"Pediatr Crit Care Med"},{"key":"2024041213283432200_jiad369-B17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.CCM.0000159854.23324.84","article-title":"Absolute and relative adrenal insufficiency in children with septic shock","volume":"33","author":"Pizarro","year":"2005","journal-title":"Crit Care Med"},{"key":"2024041213283432200_jiad369-B18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.pcc.0000256622.63135.90","article-title":"Adrenal status in children with septic shock using low-dose stimulation test","volume":"8","author":"Sarthi","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"2024041213283432200_jiad369-B19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MED.0000000000000046","article-title":"Scavenger receptor class B type I and immune dysfunctions","volume":"21","author":"Zheng","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2024041213283432200_jiad369-B20","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1161\/01.RES.0000219310.00308.10","article-title":"Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxin-induced death","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"2024041213283432200_jiad369-B21","doi-asserted-by":"crossref","first-page":"19826","DOI":"10.1074\/jbc.M109.020933","article-title":"Scavenger receptor BI protects against septic death through its role in modulating inflammatory response","volume":"284","author":"Guo","year":"2009","journal-title":"J Biol Chem"},{"key":"2024041213283432200_jiad369-B22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI31539","article-title":"SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance","volume":"118","author":"Cai","year":"2008","journal-title":"J Clin Invest"},{"key":"2024041213283432200_jiad369-B23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.1303164","article-title":"Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice","volume":"193","author":"Gilibert","year":"2014","journal-title":"J Immunol"},{"key":"2024041213283432200_jiad369-B24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1161\/ATVBAHA.120.314506","article-title":"SR-BI (scavenger receptor BI), not LDL (low-density lipoprotein) receptor, mediates adrenal stress response-brief report","volume":"40","author":"Ito","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024041213283432200_jiad369-B25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1110516","article-title":"Relative adrenal insufficiency is a risk factor and endotype of sepsis\u2014a proof-of concept study to support a precision medicine approach to guide glucocorticoid therapy for sepsis","volume":"13","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"2024041213283432200_jiad369-B26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci"},{"key":"2024041213283432200_jiad369-B27","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1002\/ams2.718","article-title":"Sepsis-associated hypoglycemia on admission is associated with increased mortality in intensive care unit patients","volume":"9","author":"Mitsuyama","year":"2022","journal-title":"Acute Med Surg"},{"key":"2024041213283432200_jiad369-B28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","article-title":"The \u201ccytokine profile\u201d: a code for sepsis","volume":"11","author":"Ulloa","year":"2005","journal-title":"Trends Mol Med"},{"key":"2024041213283432200_jiad369-B29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11908-013-0357-x","article-title":"Biomarkers in sepsis","volume":"15","author":"Walley","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"2024041213283432200_jiad369-B30","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024041213283432200_jiad369-B31","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","article-title":"Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial.","volume":"271","author":"Fisher","year":"1994","journal-title":"JAMA"},{"key":"2024041213283432200_jiad369-B32","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00003246-200107001-00037","article-title":"Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit Care Med"},{"key":"2024041213283432200_jiad369-B33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.shk.0000191343.21228.78","article-title":"Neutralization of tumor necrosis factor in preclinical models of sepsis","volume":"24 (suppl 1)","author":"Lorente","year":"2005","journal-title":"Shock"},{"key":"2024041213283432200_jiad369-B34","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"for the Soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N Engl J Med"},{"key":"2024041213283432200_jiad369-B35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells","volume":"16","author":"Galon","year":"2002","journal-title":"FASEB J"},{"key":"2024041213283432200_jiad369-B36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.270.5234.283","article-title":"Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids","volume":"270","author":"Scheinman","year":"1995","journal-title":"Science"},{"key":"2024041213283432200_jiad369-B37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(90)90395-U","article-title":"Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos\/Jun) activity by glucocorticoid hormone","volume":"62","author":"Jonat","year":"1990","journal-title":"Cell"},{"issue":"1\u20132","key":"2024041213283432200_jiad369-B38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2013.04.006","article-title":"Nuclear receptors in inflammation control: repression by GR and beyond","volume":"380","author":"Chinenov","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2024041213283432200_jiad369-B39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"2024041213283432200_jiad369-B40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"2024041213283432200_jiad369-B41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fnins.2013.00139","article-title":"Acute and chronic glucocorticoid treatments regulate astrocyte-enriched mRNAs in multiple brain regions in vivo","volume":"7","author":"Carter","year":"2013","journal-title":"Front Neurosci"},{"key":"2024041213283432200_jiad369-B42","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1097\/CCM.0000000000001264","article-title":"Corticosteroid therapy benefits septic mice with adrenal insufficiency but Harms septic mice without adrenal insufficiency","volume":"43","author":"Ai","year":"2015","journal-title":"Crit Care Med"},{"key":"2024041213283432200_jiad369-B43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1140-4","article-title":"SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis","volume":"569","author":"Huang","year":"2019","journal-title":"Nature"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad369\/51531798\/jiad369.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/4\/1166\/57223146\/jiad369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/229\/4\/1166\/57223146\/jiad369.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T13:29:06Z","timestamp":1712928546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/229\/4\/1166\/7252356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,27]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,27]]},"published-print":{"date-parts":[[2024,4,12]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad369","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4,15]]},"published":{"date-parts":[[2023,8,27]]}}}